Filomena Di Giacomo
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)University of Turin(IT)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma(2015)435 cited
- → Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications(2018)60 cited
- → Efficacy of a Cancer Vaccine against ALK -Rearranged Lung Tumors(2015)58 cited
- → RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications(2016)48 cited
- → A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation(2014)47 cited
- → Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency(2015)44 cited
- → The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1(2013)35 cited
- → Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes(2016)34 cited
- → Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities(2022)17 cited
- → IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies(2018)12 cited